Discovery Of 5-Hydroxyalkyl-4-Phenylpyridines As A New Class Of Glucagon Receptor Antagonists

5-Hydroxyalkyl-4-phenylpyridines have been identified as a novel class of glucagon antagonists with potential utility for the treatment of diabetes. A lead structure with moderate activity was discovered through a high throughput screening assay. Structure-activity relationships led to the discovery of a potent antagonist, IC50=0.11 muM, more than 60-fold improvement over the lead structure. (C) 2002 Elsevier Science Ltd. All rights reserved.